Titre : Budgets

Budgets : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Budgets : Questions médicales les plus fréquentes", "headline": "Budgets : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Budgets : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2025-03-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Budgets" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Gestion financière", "url": "https://questionsmedicales.fr/mesh/D005376", "about": { "@type": "MedicalCondition", "name": "Gestion financière", "code": { "@type": "MedicalCode", "code": "D005376", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.219.463" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Révision et fixation des tarifs", "alternateName": "Rate Setting and Review", "url": "https://questionsmedicales.fr/mesh/D011907", "about": { "@type": "MedicalCondition", "name": "Révision et fixation des tarifs", "code": { "@type": "MedicalCode", "code": "D011907", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.219.463.060.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Budgets", "alternateName": "Budgets", "code": { "@type": "MedicalCode", "code": "D002017", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Clément Delmas", "url": "https://questionsmedicales.fr/author/Cl%C3%A9ment%20Delmas", "affiliation": { "@type": "Organization", "name": "Intensive Cardiac Care Unit, Cardiology Department, Rangueil University Hospital, Toulouse, France." } }, { "@type": "Person", "name": "Mathieu Pernot", "url": "https://questionsmedicales.fr/author/Mathieu%20Pernot", "affiliation": { "@type": "Organization", "name": "Department of Cardiology and Cardiovascular Surgery, Haut-Lévèque University Hospital, Bordeaux, France." } }, { "@type": "Person", "name": "Alexandre Le Guyader", "url": "https://questionsmedicales.fr/author/Alexandre%20Le%20Guyader", "affiliation": { "@type": "Organization", "name": "Department of Thoracic and Cardiovascular Surgery, Dupuytren University Hospital, Limoges, France." } }, { "@type": "Person", "name": "Stéphane Roze", "url": "https://questionsmedicales.fr/author/St%C3%A9phane%20Roze", "affiliation": { "@type": "Organization", "name": "VYOO Agency, Lyon, France." } }, { "@type": "Person", "name": "Guillaume Lebreton", "url": "https://questionsmedicales.fr/author/Guillaume%20Lebreton", "affiliation": { "@type": "Organization", "name": "Cardiac Surgery Department, Pitié-Salpétrière Hospital, Sorbonne University, Paris, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer.", "datePublished": "2024-01-03", "url": "https://questionsmedicales.fr/article/38173005", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13058-023-01756-8" } }, { "@type": "ScholarlyArticle", "name": "Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance.", "datePublished": "2023-11-07", "url": "https://questionsmedicales.fr/article/38003213", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms242216022" } }, { "@type": "ScholarlyArticle", "name": "Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial.", "datePublished": "2023-10-20", "url": "https://questionsmedicales.fr/article/37863916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-023-42479-w" } }, { "@type": "ScholarlyArticle", "name": "miR-122 and miR-21 are Stable Components of miRNA Signatures of Early Lung Cancer after Validation in Three Independent Cohorts.", "datePublished": "2023-10-20", "url": "https://questionsmedicales.fr/article/37865291", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jmoldx.2023.09.010" } }, { "@type": "ScholarlyArticle", "name": "Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations.", "datePublished": "2023-10-18", "url": "https://questionsmedicales.fr/article/37851289", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-023-07160-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Organisations et économie des soins de santé", "item": "https://questionsmedicales.fr/mesh/D004472" }, { "@type": "ListItem", "position": 3, "name": "Économie", "item": "https://questionsmedicales.fr/mesh/D004467" }, { "@type": "ListItem", "position": 4, "name": "Gestion financière", "item": "https://questionsmedicales.fr/mesh/D005376" }, { "@type": "ListItem", "position": 5, "name": "Budgets", "item": "https://questionsmedicales.fr/mesh/D002017" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Budgets - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Budgets", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Budgets", "description": "Comment évaluer un budget de santé ?\nQuels indicateurs financiers sont utilisés ?\nQu'est-ce qu'un budget prévisionnel ?\nComment identifier les besoins budgétaires ?\nQuel rôle joue l'audit dans le budget ?", "url": "https://questionsmedicales.fr/mesh/D002017?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Budgets", "description": "Quels symptômes d'un budget déséquilibré ?\nComment détecter des anomalies budgétaires ?\nQuels signes d'une mauvaise gestion budgétaire ?\nQuels impacts d'un budget mal géré ?\nComment évaluer la santé financière d'un établissement ?", "url": "https://questionsmedicales.fr/mesh/D002017?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Budgets", "description": "Comment prévenir les dépassements budgétaires ?\nQuelles formations pour une meilleure gestion budgétaire ?\nComment sensibiliser au respect du budget ?\nQuels outils de suivi budgétaire ?\nComment établir un budget participatif ?", "url": "https://questionsmedicales.fr/mesh/D002017?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Budgets", "description": "Comment ajuster un budget de santé ?\nQuelles stratégies pour optimiser un budget ?\nComment impliquer les parties prenantes dans le budget ?\nQuels outils pour gérer un budget de santé ?\nComment évaluer l'efficacité d'un budget ?", "url": "https://questionsmedicales.fr/mesh/D002017?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Budgets", "description": "Quelles complications d'un budget mal planifié ?\nComment un budget insuffisant affecte-t-il les soins ?\nQuels risques d'un budget trop restrictif ?\nComment gérer les crises budgétaires ?\nQuels impacts d'une mauvaise allocation des fonds ?", "url": "https://questionsmedicales.fr/mesh/D002017?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Budgets", "description": "Quels facteurs influencent le budget de santé ?\nComment les changements économiques affectent-ils le budget ?\nQuels risques liés à la dépendance des financements externes ?\nComment la politique de santé impacte-t-elle le budget ?\nQuels effets des inégalités sociales sur le budget ?", "url": "https://questionsmedicales.fr/mesh/D002017?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer un budget de santé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par l'analyse des dépenses, des revenus et des besoins en santé." } }, { "@type": "Question", "name": "Quels indicateurs financiers sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent le coût par patient, le retour sur investissement et les dépenses par service." } }, { "@type": "Question", "name": "Qu'est-ce qu'un budget prévisionnel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est une estimation des dépenses et des revenus futurs pour planifier les ressources." } }, { "@type": "Question", "name": "Comment identifier les besoins budgétaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les besoins sont identifiés par l'analyse des données de santé et des tendances épidémiologiques." } }, { "@type": "Question", "name": "Quel rôle joue l'audit dans le budget ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'audit vérifie la conformité et l'efficacité des dépenses par rapport aux objectifs fixés." } }, { "@type": "Question", "name": "Quels symptômes d'un budget déséquilibré ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes incluent des retards de paiement, des pénuries de ressources et des surcoûts." } }, { "@type": "Question", "name": "Comment détecter des anomalies budgétaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les anomalies se détectent par des écarts significatifs entre prévisions et dépenses réelles." } }, { "@type": "Question", "name": "Quels signes d'une mauvaise gestion budgétaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent des dépenses excessives, un manque de transparence et des conflits d'intérêts." } }, { "@type": "Question", "name": "Quels impacts d'un budget mal géré ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un budget mal géré peut entraîner des services de santé insuffisants et une insatisfaction des patients." } }, { "@type": "Question", "name": "Comment évaluer la santé financière d'un établissement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par l'analyse des bilans, des flux de trésorerie et des ratios financiers." } }, { "@type": "Question", "name": "Comment prévenir les dépassements budgétaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une planification rigoureuse, un suivi régulier et des ajustements proactifs." } }, { "@type": "Question", "name": "Quelles formations pour une meilleure gestion budgétaire ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des formations en gestion financière, en analyse de données et en leadership sont recommandées." } }, { "@type": "Question", "name": "Comment sensibiliser au respect du budget ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La sensibilisation se fait par des campagnes d'information et des formations sur la gestion des ressources." } }, { "@type": "Question", "name": "Quels outils de suivi budgétaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les outils incluent des logiciels de comptabilité, des tableaux de bord et des rapports financiers." } }, { "@type": "Question", "name": "Comment établir un budget participatif ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un budget participatif implique les citoyens dans la planification et la décision des dépenses." } }, { "@type": "Question", "name": "Comment ajuster un budget de santé ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les ajustements se font en fonction des priorités de santé, des résultats et des ressources disponibles." } }, { "@type": "Question", "name": "Quelles stratégies pour optimiser un budget ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les stratégies incluent la réduction des coûts, l'amélioration de l'efficacité et la réallocation des ressources." } }, { "@type": "Question", "name": "Comment impliquer les parties prenantes dans le budget ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'implication se fait par des consultations, des réunions et des retours d'expérience des utilisateurs." } }, { "@type": "Question", "name": "Quels outils pour gérer un budget de santé ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les outils incluent des logiciels de gestion financière, des tableaux de bord et des analyses de données." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un budget ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité s'évalue par des indicateurs de performance et des résultats en santé mesurables." } }, { "@type": "Question", "name": "Quelles complications d'un budget mal planifié ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des retards dans les soins, des pénuries de médicaments et des crises financières." } }, { "@type": "Question", "name": "Comment un budget insuffisant affecte-t-il les soins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Un budget insuffisant peut réduire la qualité des soins, augmenter les temps d'attente et limiter l'accès." } }, { "@type": "Question", "name": "Quels risques d'un budget trop restrictif ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un budget restrictif peut entraîner des coupes dans les services essentiels et affecter la santé publique." } }, { "@type": "Question", "name": "Comment gérer les crises budgétaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des crises nécessite des plans d'urgence, des réallocations rapides et des partenariats stratégiques." } }, { "@type": "Question", "name": "Quels impacts d'une mauvaise allocation des fonds ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise allocation peut entraîner des inégalités dans l'accès aux soins et des résultats de santé dégradés." } }, { "@type": "Question", "name": "Quels facteurs influencent le budget de santé ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la démographie, les maladies chroniques, et les politiques de santé." } }, { "@type": "Question", "name": "Comment les changements économiques affectent-ils le budget ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les changements économiques peuvent réduire les financements publics et augmenter les coûts des soins." } }, { "@type": "Question", "name": "Quels risques liés à la dépendance des financements externes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La dépendance peut entraîner des instabilités budgétaires et des restrictions sur les priorités de santé." } }, { "@type": "Question", "name": "Comment la politique de santé impacte-t-elle le budget ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La politique de santé détermine les priorités de financement et l'allocation des ressources disponibles." } }, { "@type": "Question", "name": "Quels effets des inégalités sociales sur le budget ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les inégalités sociales peuvent augmenter les coûts de santé et nécessiter des dépenses supplémentaires." } } ] } ] }

Sources (10000 au total)

A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer.

Neoadjuvant endocrine therapy (NET) in oestrogen receptor-positive (ER+) /HER2-negative (HER2-) breast cancer allows real-time evaluation of drug efficacy as well as investigation of the biological an... In this prospective study, we extensively analysed radiological (by ultrasound scan (USS) and magnetic resonance imaging (MRI)) and pathological tumour response of 104 postmenopausal patients with ER+... Our results show that radiological evaluation of response to NET by both USS and MRI underestimates pathological tumour size (path-TS). Tumour size [mean (range); mm] was: path-TS 20 (0-80); radiologi... Our findings shed light on the dynamics of tumour response to NET, challenge the paradigm of the ability of NET to decrease surgical volume and point to the utility of the TCS to quantify the scattere...

Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations.

Mastectomy, breast reconstruction (BR) and breast conserving therapy (BCT) are core components of the treatment paradigm for early-stage disease but are differentially associated with significant fina... For this cross-sectional analysis, cost reports were obtained from the Turquoise Health price transparency platform for all U.S. hospitals meeting national accreditation standards for breast cancer ca... Of 447 identified hospitals, 221 (49.4%) disclosed prices for mastectomy and 188 42.1%) disclosed prices for both mastectomy and some form of reconstruction including oncoplastic reduction (n = 184, 9... Most eligible hospitals did not disclose prices for breast cancer surgery. Distinct hospital characteristics were associated with price disclosure. Breast cancer patients face persistent difficulty in...

A Clinical Analysis of Prognosis and Patient-Reported Outcomes of Oncoplastic Breast-Conserving Surgery for Early Breast Cancer: A Retrospective Cohort Study.

Approximately 25-30% of patients suffer from breast deformity and/or asymmetry after conventional breast-conserving surgery (CBCS). Generally, it is thought that oncoplastic breast-conserving surgery ... A total of 143 patients were included in this retrospective cohort study; 53 underwent OBCS and 90 underwent CBCS. The resected weight, complications, esthetic results, patient satisfaction, and recur... The mean age of the patients in OBCS group was 43.8 years. This was younger than that in CBCS group (49.1 years, p < 0.001). Postoperative complications (11.3% vs. 8.9%, p = 0.64) and re-excision (5.7... Although OBCS has the better aesthetic outcomes and identical oncological safety in comparison with CBCS, the sexual and physical well-being in OBCS are not improved for Asian patients. Hence, choosin... This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...

Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.

Surgical strategy for second primary lung cancer (SPLC) may be more conservative due to influence of first primary lung cancer (FPLC). The optimal surgical method for SPLC warrants discussion. We aime... A retrospective study was conducted using data from the Surveillance, Epidemiology and End Results database between 2004 and 2018, and data of patients with early-stage SPLC who underwent secondary su... A total of 714 patients who met the study entry criteria were enrolled, including 476 patients in the sublobar resection group (66.67%) and 238 patients in the lobar resection group (33.33%). There wa... The OS of sublobar resection was not significantly different from that of lobar resection for early-stage SPLC. For SPLC with a 2-3 cm tumor size, lobar resection is more advantageous than sublobar re...

An optimal dose-fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early-stage non-small lung cancer.

Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early-stage non-small lung cancer (NSCLC). This treatment h...

Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study.

The study aimed to compare the survival outcomes and efficacy of platinum in early breast cancer patients with BRCA1 and BRCA2 mutations.... Patients diagnosed with stage I-III breast cancer and carrying germline pathogenic/likely pathogenic BRCA mutations in three medical institutions in China from April 2016 to January 2021 were retrospe... One hundred and sixty-nine patients with BRCA mutations were enrolled, including BRCA1 mutation (53.3%, n = 90) and BRCA2 mutation (46.7%, n = 79). The median age was 39 years, and most patients (68.1... Similar survival outcomes were observed in early breast cancer patients with BRCA1 and BRCA2 mutation, though they had different biological characteristics. Patients with BRCA1 mutations are more bene...

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative.

With global adoption of computed tomography (CT) lung cancer screening, there is increasing interest to use artificial intelligence (AI) deep learning methods to improve the clinical management proces... In this second phase of the initiative, metadata and screening CT scans from two time points were collected from 100 screening participants in seven countries. An automated deep learning AI lung segme... A total of 1394 CTs were collected from 697 participants. The LAV950 quantitative emphysema metric was found to be potentially useful in distinguishing lung cancer from benign cases using a combined s... These initial experiments revealed that ELIC can support deep learning AI and quantitative imaging analyses on diverse and globally distributed cloud-based data sets....